{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T14:50:13Z","timestamp":1774450213075,"version":"3.50.1"},"reference-count":33,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011892","name":"Kaohsiung Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8H0871"],"award-info":[{"award-number":["CMRPG8H0871"]}],"id":[{"id":"10.13039\/501100011892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Nutrients"],"abstract":"<jats:p>The prevalence of metabolic syndrome (MetS) is increasing, and patients with MetS are at an increased risk of cardiovascular disease and diabetes. There is a close link between hypomagnesemia and MetS. Administration of sodium-glucose transporter 2 (SGLT2) inhibitors has been reported to increase serum magnesium levels in patients with diabetes. We investigated the alterations in renal magnesium handling in an animal model of MetS and analyzed the effects of SGLT2 inhibitors. Adult rats were fed a fructose-rich diet to induce MetS in the first 3 months and were then treated with either dapagliflozin or magnesium sulfate-containing drinking water for another 3 months. Fructose-fed animals had increased insulin resistance, hypomagnesemia, and decreased urinary magnesium excretion. Dapagliflozin treatment improved insulin resistance by decreasing glucose and insulin levels, increased serum magnesium levels, and reduced urinary magnesium excretion. Serum vitamin D and parathyroid hormone levels were decreased in fructose-fed animals, and the levels remained low despite dapagliflozin and magnesium supplementation. In the kidney, claudin-16, TRPM6\/7, and FXDY expression was increased in fructose-fed animals. Dapagliflozin increased intracellular magnesium concentration, and this effect was inhibited by TRPM6 blockade and the EGFR antagonist. We concluded that high fructose intake combined with a low-magnesium diet induced MetS and hypomagnesemia. Both dapagliflozin and magnesium sulfate supplementation improved the features of MetS and increased serum magnesium levels. Expression levels of magnesium transporters such as claudin-16, TRPM6\/7, and FXYD2 were increased in fructose-fed animals and in those administered dapagliflozin and magnesium sulfate. Dapagliflozin enhances TRPM6-mediated trans-epithelial magnesium transport in renal tubule cells.<\/jats:p>","DOI":"10.3390\/nu13114088","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T20:46:47Z","timestamp":1637009207000},"page":"4088","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Effect of Dapagliflozin and Magnesium Supplementation on Renal Magnesium Handling and Magnesium Homeostasis in Metabolic Syndrome"],"prefix":"10.3390","volume":"13","author":[{"given":"Hwee-Yeong","family":"Ng","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Hung","family":"Kuo","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7059-6407","authenticated-orcid":false,"given":"You-Lin","family":"Tain","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Foong-Fah","family":"Leung","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6172-1483","authenticated-orcid":false,"given":"Wen-Chin","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4704-1956","authenticated-orcid":false,"given":"Chien-Te","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,15]]},"reference":[{"key":"ref_1","first-page":"747861","article-title":"Metabolic syndrome, chronic kidney disease, and cardiovascular disease: A dynamic and life-threatening triad","volume":"20","author":"Raimundo","year":"2011","journal-title":"Cardiol. Res. Pract."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.2337\/db12-1814","article-title":"Sugar, uric acid, and the etiology of diabetes and obesity","volume":"62","author":"Johnson","year":"2013","journal-title":"Diabetes"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Rosique-Esteban, N., Guasch-Ferr\u00e9, M., Hern\u00e1ndez-Alonso, P., and Salas-Salvad\u00f3, J. (2018). Dietary magnesium and cardiovascular disease: A review with emphasis in epidemiological studies. Nutrients, 10.","DOI":"10.3390\/nu10020168"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00125-017-4224-4","article-title":"Serum magnesium and the risk of prediabetes: A population-based cohort study","volume":"60","author":"Kieboom","year":"2017","journal-title":"Diabetologia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00394-008-0715-x","article-title":"Dietary magnesium intake is related to metabolic syndrome in older Americans","volume":"47","author":"McKeown","year":"2008","journal-title":"Eur. J. Nutr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12011-009-8465-z","article-title":"Implications of magnesium deficiency in type 2 diabetes: A review","volume":"134","author":"Chaudhary","year":"2010","journal-title":"Biol. Trace Elem. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2215\/CJN.02960906","article-title":"Hypomagnesemia in patients with type 2 diabetes","volume":"2","author":"Pham","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00467-016-3416-3","article-title":"Genetic cause of hypomagnesemia, a clinical overview","volume":"32","author":"Viering","year":"2017","journal-title":"Pediatr. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2011.05.010","article-title":"Cellular magnesium homeostasis","volume":"512","author":"Romani","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1042\/BJ20140409","article-title":"Nucleotide binding triggers a conformational change of the CBS module of the magnesium transporter CNNM2 from a twisted towards a flat structure","volume":"464","author":"Stuiver","year":"2014","journal-title":"Biochem. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"F1027","DOI":"10.1152\/ajprenal.00634.2017","article-title":"The rise and fall of novel renal magnesium transporters","volume":"314","author":"Hoenderop","year":"2018","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/ndt\/gfu299","article-title":"Sodium-glucose contransport inhibitors: Mechanisms, metabolic effects and implications for the treatment of diabetic patients with chronic kidney disease","volume":"30","author":"Vlotides","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1007\/s00125-016-4101-6","article-title":"Elevated serum magnesium associated with SGLT2 inhibitor use in type 2 diabetes patients: A meta-analysis of randomized controlled trials","volume":"59","author":"Tang","year":"2016","journal-title":"Diabetologia"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/db15-1028","article-title":"Hypomagnesemia in type 2 diabetes: A vicious circle?","volume":"65","author":"Gommers","year":"2016","journal-title":"Diabetes"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kostov, K. (2019). Effects of magnesium deficiency on mechanisms of insulin resistance in type 2 diabetes: Focusing on the processes of insulin secretion and signaling. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061351"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/JIR.S136742","article-title":"Magnesium deficiency and increased inflammation: Current perspectives","volume":"11","author":"Nielsen","year":"2018","journal-title":"J. Inflamm. Res."},{"key":"ref_17","first-page":"237","article-title":"High fructose consumption combined with low dietary magnesium intake may increase the incidence of the metabolic syndrome by inducing inflammation","volume":"19","author":"Rayssiguier","year":"2006","journal-title":"Magnes. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e13843","DOI":"10.14814\/phy2.13843","article-title":"Renal Mg handling, FXYD2 and the central role of the Na, K-ATPase","volume":"6","author":"Mayan","year":"2018","journal-title":"Physiol. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00012.2014","article-title":"Magnesium in man: Implications for health and disease","volume":"95","author":"Hoenderop","year":"2015","journal-title":"Physiol. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"R2001","DOI":"10.1152\/ajpregu.00153.2007","article-title":"Relationship between low magnesium status and TRPM6 expression in the kidney and large intestine","volume":"294","author":"Groenestege","year":"2008","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"107402","DOI":"10.1016\/j.jdiacomp.2019.06.007","article-title":"Correction of hypomagnesemia by dapagliflozin in patients with type 2 diabetes: A post hoc analysis of 10 randomized, placebo-controlled trials","volume":"33","author":"Toto","year":"2019","journal-title":"J. Diabetes Complicat."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.dsx.2017.08.003","article-title":"SGLT2 inhibitors-induced electrolyte abnormalities: An analysis of the associated mechanisms","volume":"12","author":"Filippatos","year":"2018","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Cianciolo, G., Pascalis, A.D.D., Gasperoni, L., Tondolo, F., Zappulo, F., Capelli, I., Cappuccili, M., and Manna, G.L.L. (2020). The off-target effects, electrolyte and mineral disorders of SGLT2i. Molecules, 25.","DOI":"10.3390\/molecules25122757"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MNH.0000000000000632","article-title":"Tubular effects of sodium-glucose cotransporter 2 inhibitors: Intended and unintended consequences","volume":"29","author":"Rieg","year":"2020","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1042\/CS20201274","article-title":"SGLT2 inhibition versus sulfonylurea treatment effects on analysis of a clinical trial reaching glycemic equipoise: Tubular effects of SGLT2 inhibition in type 2 diabetes","volume":"134","author":"Geurts","year":"2020","journal-title":"Clin. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"E1303","DOI":"10.1152\/ajpendo.00582.2012","article-title":"Excessive fructose intake causes 1,25-(OH)2D3-dependent inhibition of intestinal and renal calcium transport in growing rats","volume":"304","author":"Douard","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_28","first-page":"47","article-title":"Magnesium metabolism and its disorders","volume":"24","author":"Swaminathan","year":"2003","journal-title":"Clin. Biochem. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7556\/jaoa.2018.037","article-title":"Role of magnesium in vitamin D activation and function","volume":"118","author":"Uwitonze","year":"2018","journal-title":"J. Am. Osteopath. Assoc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1210\/jc.2015-3909","article-title":"Presentation of hypoparathyroidism: Etiologies and clinical features","volume":"101","author":"Shoback","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1681\/ASN.2007111194","article-title":"Clinical consequences and management of hypomagnesemia","volume":"20","author":"Martin","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2215\/CJN.09750913","article-title":"Renal control of calcium, phosphate, and magnesium homeostasis","volume":"10","author":"Blaine","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12902-017-0221-3","article-title":"Vitamin D, parathyroid hormone and metabolic syndrome\u2014the PORMETS study","volume":"17","author":"Raposo","year":"2017","journal-title":"BMC Endocr. Disord."}],"updated-by":[{"DOI":"10.3390\/nu16193413","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000}}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/11\/4088\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T22:26:16Z","timestamp":1754259976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/11\/4088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":33,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["nu13114088"],"URL":"https:\/\/doi.org\/10.3390\/nu13114088","relation":{"correction":[{"id-type":"doi","id":"10.3390\/nu16193413","asserted-by":"object"}]},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,15]]}}}